Lake Street Reiterates Buy on TELA Bio, Maintains $14 Price Target
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Frank Takkinen has reiterated a Buy rating on TELA Bio (NASDAQ:TELA) and maintained a $14 price target on the company's stock.
December 27, 2023 | 2:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Lake Street analyst Frank Takkinen reaffirmed a Buy rating on TELA Bio with a $14 price target, indicating a positive outlook on the stock.
The reiteration of a Buy rating and maintenance of a $14 price target by a reputable analyst like Frank Takkinen could instill confidence in investors and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100